has received an investment from
Cascadia Capital is pleased to announce that its client, Nutraceutical Research Innovations (NRI, LLC), the brand incubator behind the renowned haircare brands ZENAGAN and ACT/IV, has secured an investment from Auréa, a private equity firm specializing in beauty, wellness, and longevity.
Recognized for their award-winning, professional-grade vegan and botanically focused formulas, ZENAGEN and ACT/IV have become salon favorites. Biochemist Jared Reynolds, CEO and Founder of NRI, has been instrumental in developing plant-based, nutrient-rich products specifically designed to address hair thinning, shedding, and scalp care. The phytonutrient-rich formulations have efficacy that have cultivated a loyal following in the salon professional channel, with the brands now available in more than 30,000 salons across the U.S. and internationally.
The brands’ focus on biochemistry-driven benefits for hair and scalp health underpins NRI’s innovative product development. Its product lines cater to specific hair concerns, including fine and thinning hair, as well as scalp irritation and dandruff.
The investment from Auréa is expected to drive significant growth for NRI, enabling the company to expand its professional channel presence to reach new salon markets, both domestically and internationally, and accelerate digital transformation and e-commerce capabilities, enhancing accessibility and customer engagement.
“We are thrilled to partner with Auréa to further the growth of our brands,” said Mr. Reynolds. “We have been deliberate in selecting a partner who brings significant value to our vision. Auréa’s expertise in the professional hair care industry and deep knowledge of the digital beauty landscape makes them the perfect fit. We are excited for the future.”
Cascadia Capital served as the exclusive financial advisor to Nutraceutical Research Innovations, LLC in this transaction. The partnership reflects Cascadia’s deep expertise in the beauty and personal care sector and its commitment to supporting high-growth, purpose-driven brands.
“Cascadia couldn’t be happier for Jared and the team at NRI,” shared William Susman, Managing Director at Cascadia Capital. “He has built an amazing company rooted in innovation, delivering products that customers cannot get enough of. We are excited to see how the Auréa partnership will elevate the company to even greater heights.”
“This transaction underscores the strength of Cascadia’s Beauty and Personal Care investment banking practice,” added Ilya Seglin, Managing Director at Cascadia Capital. “We are proud to support purpose-driven brands like Zenagen and ACT/IV that are transforming their industries. Our team remains committed to driving exceptional outcomes for clients in the beauty and wellness space.”
Recent Transactions
This acquisition represents another successful transaction for Cascadia’s Consumer, Retail & E-Commerce group in the beauty & wellness sector. Past transactions include:
a portfolio company of
has been acquired by
